nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFA5—psoriasis	0.66	1	CbGaD
Metformin—NDUFS6—skin of body—psoriasis	0.00181	0.0319	CbGeAlD
Metformin—NDUFA9—skin of body—psoriasis	0.00148	0.026	CbGeAlD
Metformin—NDUFA13—skin of body—psoriasis	0.00148	0.026	CbGeAlD
Metformin—NDUFA7—tendon—psoriasis	0.00134	0.0237	CbGeAlD
Metformin—ND2—skin of body—psoriasis	0.00129	0.0228	CbGeAlD
Metformin—ND5—skin of body—psoriasis	0.00129	0.0228	CbGeAlD
Metformin—ND3—skin of body—psoriasis	0.00129	0.0228	CbGeAlD
Metformin—ND4L—skin of body—psoriasis	0.00129	0.0228	CbGeAlD
Metformin—ND4—skin of body—psoriasis	0.00125	0.022	CbGeAlD
Metformin—NDUFA10—skin of body—psoriasis	0.00117	0.0206	CbGeAlD
Metformin—NDUFC1—skin of body—psoriasis	0.00116	0.0204	CbGeAlD
Metformin—ND6—skin of body—psoriasis	0.00113	0.0199	CbGeAlD
Metformin—NDUFA5—skin of body—psoriasis	0.00109	0.0193	CbGeAlD
Metformin—NDUFB6—skin of body—psoriasis	0.00108	0.0191	CbGeAlD
Metformin—NDUFS1—skin of body—psoriasis	0.00108	0.019	CbGeAlD
Metformin—NDUFB10—skin of body—psoriasis	0.00107	0.0189	CbGeAlD
Metformin—NDUFA4L2—tendon—psoriasis	0.00104	0.0184	CbGeAlD
Metformin—NDUFB5—skin of body—psoriasis	0.00104	0.0183	CbGeAlD
Metformin—NDUFAB1—skin of body—psoriasis	0.00101	0.0179	CbGeAlD
Metformin—NDUFB9—skin of body—psoriasis	0.00101	0.0178	CbGeAlD
Metformin—NDUFA4—skin of body—psoriasis	0.001	0.0177	CbGeAlD
Metformin—NDUFV1—skin of body—psoriasis	0.000995	0.0176	CbGeAlD
Metformin—NDUFS5—skin of body—psoriasis	0.000989	0.0174	CbGeAlD
Metformin—NDUFB8—skin of body—psoriasis	0.000989	0.0174	CbGeAlD
Metformin—NDUFA2—tendon—psoriasis	0.000931	0.0164	CbGeAlD
Metformin—NDUFA10—tendon—psoriasis	0.000888	0.0157	CbGeAlD
Metformin—NDUFC1—tendon—psoriasis	0.00088	0.0155	CbGeAlD
Metformin—NDUFB2—tendon—psoriasis	0.000873	0.0154	CbGeAlD
Metformin—NDUFAF1—tendon—psoriasis	0.000865	0.0153	CbGeAlD
Metformin—NDUFB3—tendon—psoriasis	0.000851	0.015	CbGeAlD
Metformin—NDUFAF2—tendon—psoriasis	0.000851	0.015	CbGeAlD
Metformin—NDUFA11—tendon—psoriasis	0.000832	0.0147	CbGeAlD
Metformin—NDUFB6—tendon—psoriasis	0.000825	0.0146	CbGeAlD
Metformin—NDUFAF4—tendon—psoriasis	0.000825	0.0146	CbGeAlD
Metformin—NDUFS1—tendon—psoriasis	0.000819	0.0145	CbGeAlD
Metformin—NDUFB10—tendon—psoriasis	0.000814	0.0144	CbGeAlD
Metformin—NDUFA12—tendon—psoriasis	0.000808	0.0143	CbGeAlD
Metformin—NDUFB7—tendon—psoriasis	0.000808	0.0143	CbGeAlD
Metformin—NDUFS8—tendon—psoriasis	0.000802	0.0142	CbGeAlD
Metformin—NDUFB1—tendon—psoriasis	0.000802	0.0142	CbGeAlD
Metformin—NDUFB5—tendon—psoriasis	0.000791	0.014	CbGeAlD
Metformin—NDUFA6—tendon—psoriasis	0.000791	0.014	CbGeAlD
Metformin—NDUFS4—tendon—psoriasis	0.000786	0.0139	CbGeAlD
Metformin—NDUFB4—tendon—psoriasis	0.000776	0.0137	CbGeAlD
Metformin—NDUFAB1—tendon—psoriasis	0.000771	0.0136	CbGeAlD
Metformin—NDUFS2—skin of body—psoriasis	0.000768	0.0135	CbGeAlD
Metformin—NDUFB9—tendon—psoriasis	0.000766	0.0135	CbGeAlD
Metformin—NDUFA8—tendon—psoriasis	0.000766	0.0135	CbGeAlD
Metformin—NDUFA4—tendon—psoriasis	0.000762	0.0134	CbGeAlD
Metformin—NDUFS3—skin of body—psoriasis	0.000758	0.0134	CbGeAlD
Metformin—NDUFV1—tendon—psoriasis	0.000757	0.0134	CbGeAlD
Metformin—NDUFB11—tendon—psoriasis	0.000757	0.0134	CbGeAlD
Metformin—NDUFB8—tendon—psoriasis	0.000753	0.0133	CbGeAlD
Metformin—NDUFS5—tendon—psoriasis	0.000753	0.0133	CbGeAlD
Metformin—NDUFS7—tendon—psoriasis	0.000705	0.0124	CbGeAlD
Metformin—PRKAB1—tendon—psoriasis	0.000645	0.0114	CbGeAlD
Metformin—NDUFAF4—Levonorgestrel—Hydrocortisone—psoriasis	0.000634	1	CbGdCrCtD
Metformin—ND1—skin of body—psoriasis	0.00063	0.0111	CbGeAlD
Metformin—NDUFC2—tendon—psoriasis	0.000608	0.0107	CbGeAlD
Metformin—NDUFS2—tendon—psoriasis	0.000585	0.0103	CbGeAlD
Metformin—NDUFS3—tendon—psoriasis	0.000577	0.0102	CbGeAlD
Metformin—SLC47A1—tendon—psoriasis	0.000326	0.00575	CbGeAlD
Metformin—Decreased appetite—Cyclosporine—psoriasis	7.14e-05	0.000598	CcSEcCtD
Metformin—Somnolence—Mycophenolate mofetil—psoriasis	7.12e-05	0.000597	CcSEcCtD
Metformin—Infestation—Methotrexate—psoriasis	7.12e-05	0.000596	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—psoriasis	7.12e-05	0.000596	CcSEcCtD
Metformin—Drowsiness—Methotrexate—psoriasis	7.12e-05	0.000596	CcSEcCtD
Metformin—Flushing—Prednisone—psoriasis	7.1e-05	0.000594	CcSEcCtD
Metformin—Gastrointestinal disorder—Cyclosporine—psoriasis	7.09e-05	0.000594	CcSEcCtD
Metformin—Skin disorder—Hydrocortisone—psoriasis	7.09e-05	0.000594	CcSEcCtD
Metformin—Ill-defined disorder—Betamethasone—psoriasis	7.09e-05	0.000594	CcSEcCtD
Metformin—Ill-defined disorder—Dexamethasone—psoriasis	7.09e-05	0.000594	CcSEcCtD
Metformin—Discomfort—Triamcinolone—psoriasis	7.08e-05	0.000593	CcSEcCtD
Metformin—Fatigue—Cyclosporine—psoriasis	7.08e-05	0.000593	CcSEcCtD
Metformin—Hyperhidrosis—Hydrocortisone—psoriasis	7.06e-05	0.000591	CcSEcCtD
Metformin—Dyspepsia—Mycophenolate mofetil—psoriasis	7.05e-05	0.000591	CcSEcCtD
Metformin—Constipation—Cyclosporine—psoriasis	7.02e-05	0.000588	CcSEcCtD
Metformin—Decreased appetite—Mycophenolate mofetil—psoriasis	6.97e-05	0.000583	CcSEcCtD
Metformin—Anorexia—Hydrocortisone—psoriasis	6.96e-05	0.000583	CcSEcCtD
Metformin—Diarrhoea—Mycophenolic acid—psoriasis	6.95e-05	0.000582	CcSEcCtD
Metformin—Angiopathy—Prednisone—psoriasis	6.94e-05	0.000581	CcSEcCtD
Metformin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	6.92e-05	0.000579	CcSEcCtD
Metformin—Immune system disorder—Prednisone—psoriasis	6.91e-05	0.000578	CcSEcCtD
Metformin—Malaise—Dexamethasone—psoriasis	6.89e-05	0.000577	CcSEcCtD
Metformin—Malaise—Betamethasone—psoriasis	6.89e-05	0.000577	CcSEcCtD
Metformin—Oedema—Triamcinolone—psoriasis	6.87e-05	0.000576	CcSEcCtD
Metformin—Syncope—Betamethasone—psoriasis	6.85e-05	0.000574	CcSEcCtD
Metformin—Syncope—Dexamethasone—psoriasis	6.85e-05	0.000574	CcSEcCtD
Metformin—Constipation—Mycophenolate mofetil—psoriasis	6.85e-05	0.000574	CcSEcCtD
Metformin—Infection—Triamcinolone—psoriasis	6.83e-05	0.000572	CcSEcCtD
Metformin—Hypotension—Hydrocortisone—psoriasis	6.82e-05	0.000571	CcSEcCtD
Metformin—Feeling abnormal—Cyclosporine—psoriasis	6.77e-05	0.000567	CcSEcCtD
Metformin—Shock—Triamcinolone—psoriasis	6.76e-05	0.000566	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—psoriasis	6.73e-05	0.000564	CcSEcCtD
Metformin—Gastrointestinal pain—Cyclosporine—psoriasis	6.72e-05	0.000563	CcSEcCtD
Metformin—Loss of consciousness—Betamethasone—psoriasis	6.72e-05	0.000563	CcSEcCtD
Metformin—Loss of consciousness—Dexamethasone—psoriasis	6.72e-05	0.000563	CcSEcCtD
Metformin—Dizziness—Mycophenolic acid—psoriasis	6.71e-05	0.000562	CcSEcCtD
Metformin—Paraesthesia—Prednisolone—psoriasis	6.71e-05	0.000562	CcSEcCtD
Metformin—Erythema—Prednisone—psoriasis	6.66e-05	0.000557	CcSEcCtD
Metformin—Malnutrition—Prednisone—psoriasis	6.66e-05	0.000557	CcSEcCtD
Metformin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	6.65e-05	0.000557	CcSEcCtD
Metformin—Hyperhidrosis—Triamcinolone—psoriasis	6.65e-05	0.000556	CcSEcCtD
Metformin—Feeling abnormal—Mycophenolate mofetil—psoriasis	6.6e-05	0.000553	CcSEcCtD
Metformin—Hypertension—Betamethasone—psoriasis	6.6e-05	0.000553	CcSEcCtD
Metformin—Hypertension—Dexamethasone—psoriasis	6.6e-05	0.000553	CcSEcCtD
Metformin—Paraesthesia—Hydrocortisone—psoriasis	6.56e-05	0.000549	CcSEcCtD
Metformin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	6.55e-05	0.000549	CcSEcCtD
Metformin—Urticaria—Cyclosporine—psoriasis	6.53e-05	0.000546	CcSEcCtD
Metformin—Myalgia—Dexamethasone—psoriasis	6.51e-05	0.000545	CcSEcCtD
Metformin—Myalgia—Betamethasone—psoriasis	6.51e-05	0.000545	CcSEcCtD
Metformin—Abdominal pain—Cyclosporine—psoriasis	6.49e-05	0.000544	CcSEcCtD
Metformin—Vomiting—Mycophenolic acid—psoriasis	6.46e-05	0.000541	CcSEcCtD
Metformin—Discomfort—Betamethasone—psoriasis	6.43e-05	0.000538	CcSEcCtD
Metformin—Discomfort—Dexamethasone—psoriasis	6.43e-05	0.000538	CcSEcCtD
Metformin—Dyspepsia—Hydrocortisone—psoriasis	6.43e-05	0.000538	CcSEcCtD
Metformin—Rash—Mycophenolic acid—psoriasis	6.4e-05	0.000536	CcSEcCtD
Metformin—Dermatitis—Mycophenolic acid—psoriasis	6.4e-05	0.000536	CcSEcCtD
Metformin—Hepatitis—Methotrexate—psoriasis	6.39e-05	0.000535	CcSEcCtD
Metformin—Urticaria—Mycophenolate mofetil—psoriasis	6.37e-05	0.000533	CcSEcCtD
Metformin—Headache—Mycophenolic acid—psoriasis	6.36e-05	0.000533	CcSEcCtD
Metformin—Decreased appetite—Hydrocortisone—psoriasis	6.35e-05	0.000531	CcSEcCtD
Metformin—Abdominal pain—Mycophenolate mofetil—psoriasis	6.33e-05	0.00053	CcSEcCtD
Metformin—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.3e-05	0.000528	CcSEcCtD
Metformin—Fatigue—Hydrocortisone—psoriasis	6.29e-05	0.000527	CcSEcCtD
Metformin—Vision blurred—Prednisone—psoriasis	6.27e-05	0.000525	CcSEcCtD
Metformin—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.26e-05	0.000524	CcSEcCtD
Metformin—Oedema—Betamethasone—psoriasis	6.24e-05	0.000522	CcSEcCtD
Metformin—Oedema—Dexamethasone—psoriasis	6.24e-05	0.000522	CcSEcCtD
Metformin—Infection—Betamethasone—psoriasis	6.2e-05	0.000519	CcSEcCtD
Metformin—Infection—Dexamethasone—psoriasis	6.2e-05	0.000519	CcSEcCtD
Metformin—Ill-defined disorder—Prednisone—psoriasis	6.17e-05	0.000517	CcSEcCtD
Metformin—Paraesthesia—Triamcinolone—psoriasis	6.17e-05	0.000517	CcSEcCtD
Metformin—Feeling abnormal—Prednisolone—psoriasis	6.16e-05	0.000516	CcSEcCtD
Metformin—Shock—Dexamethasone—psoriasis	6.14e-05	0.000514	CcSEcCtD
Metformin—Shock—Betamethasone—psoriasis	6.14e-05	0.000514	CcSEcCtD
Metformin—Dyspnoea—Triamcinolone—psoriasis	6.13e-05	0.000513	CcSEcCtD
Metformin—Nervous system disorder—Betamethasone—psoriasis	6.12e-05	0.000512	CcSEcCtD
Metformin—Nervous system disorder—Dexamethasone—psoriasis	6.12e-05	0.000512	CcSEcCtD
Metformin—Thrombocytopenia—Dexamethasone—psoriasis	6.11e-05	0.000511	CcSEcCtD
Metformin—Thrombocytopenia—Betamethasone—psoriasis	6.11e-05	0.000511	CcSEcCtD
Metformin—Dyspepsia—Triamcinolone—psoriasis	6.05e-05	0.000507	CcSEcCtD
Metformin—Nausea—Mycophenolic acid—psoriasis	6.03e-05	0.000505	CcSEcCtD
Metformin—Hyperhidrosis—Dexamethasone—psoriasis	6.03e-05	0.000505	CcSEcCtD
Metformin—Hyperhidrosis—Betamethasone—psoriasis	6.03e-05	0.000505	CcSEcCtD
Metformin—Feeling abnormal—Hydrocortisone—psoriasis	6.02e-05	0.000504	CcSEcCtD
Metformin—Malaise—Prednisone—psoriasis	6e-05	0.000503	CcSEcCtD
Metformin—Eye disorder—Methotrexate—psoriasis	5.97e-05	0.0005	CcSEcCtD
Metformin—Gastrointestinal pain—Hydrocortisone—psoriasis	5.97e-05	0.0005	CcSEcCtD
Metformin—Syncope—Prednisone—psoriasis	5.97e-05	0.0005	CcSEcCtD
Metformin—Anorexia—Betamethasone—psoriasis	5.95e-05	0.000498	CcSEcCtD
Metformin—Anorexia—Dexamethasone—psoriasis	5.95e-05	0.000498	CcSEcCtD
Metformin—Urticaria—Prednisolone—psoriasis	5.94e-05	0.000497	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—psoriasis	5.93e-05	0.000497	CcSEcCtD
Metformin—Fatigue—Triamcinolone—psoriasis	5.93e-05	0.000496	CcSEcCtD
Metformin—Asthenia—Cyclosporine—psoriasis	5.89e-05	0.000494	CcSEcCtD
Metformin—Loss of consciousness—Prednisone—psoriasis	5.85e-05	0.00049	CcSEcCtD
Metformin—Hypotension—Dexamethasone—psoriasis	5.83e-05	0.000488	CcSEcCtD
Metformin—Hypotension—Betamethasone—psoriasis	5.83e-05	0.000488	CcSEcCtD
Metformin—Pruritus—Cyclosporine—psoriasis	5.81e-05	0.000487	CcSEcCtD
Metformin—Urticaria—Hydrocortisone—psoriasis	5.8e-05	0.000486	CcSEcCtD
Metformin—Angiopathy—Methotrexate—psoriasis	5.8e-05	0.000485	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—psoriasis	5.77e-05	0.000483	CcSEcCtD
Metformin—Abdominal pain—Hydrocortisone—psoriasis	5.77e-05	0.000483	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—psoriasis	5.76e-05	0.000482	CcSEcCtD
Metformin—Asthenia—Mycophenolate mofetil—psoriasis	5.75e-05	0.000481	CcSEcCtD
Metformin—Hypertension—Prednisone—psoriasis	5.75e-05	0.000481	CcSEcCtD
Metformin—Chills—Methotrexate—psoriasis	5.73e-05	0.00048	CcSEcCtD
Metformin—Musculoskeletal discomfort—Betamethasone—psoriasis	5.68e-05	0.000476	CcSEcCtD
Metformin—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.68e-05	0.000476	CcSEcCtD
Metformin—Pruritus—Mycophenolate mofetil—psoriasis	5.67e-05	0.000475	CcSEcCtD
Metformin—Myalgia—Prednisone—psoriasis	5.67e-05	0.000475	CcSEcCtD
Metformin—Feeling abnormal—Triamcinolone—psoriasis	5.66e-05	0.000474	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.63e-05	0.000471	CcSEcCtD
Metformin—Diarrhoea—Cyclosporine—psoriasis	5.62e-05	0.000471	CcSEcCtD
Metformin—Paraesthesia—Dexamethasone—psoriasis	5.6e-05	0.000469	CcSEcCtD
Metformin—Paraesthesia—Betamethasone—psoriasis	5.6e-05	0.000469	CcSEcCtD
Metformin—Discomfort—Prednisone—psoriasis	5.6e-05	0.000469	CcSEcCtD
Metformin—Erythema—Methotrexate—psoriasis	5.56e-05	0.000466	CcSEcCtD
Metformin—Malnutrition—Methotrexate—psoriasis	5.56e-05	0.000466	CcSEcCtD
Metformin—Dyspepsia—Betamethasone—psoriasis	5.49e-05	0.00046	CcSEcCtD
Metformin—Dyspepsia—Dexamethasone—psoriasis	5.49e-05	0.00046	CcSEcCtD
Metformin—Diarrhoea—Mycophenolate mofetil—psoriasis	5.48e-05	0.000459	CcSEcCtD
Metformin—Urticaria—Triamcinolone—psoriasis	5.46e-05	0.000457	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—psoriasis	5.45e-05	0.000456	CcSEcCtD
Metformin—Dizziness—Cyclosporine—psoriasis	5.43e-05	0.000455	CcSEcCtD
Metformin—Oedema—Prednisone—psoriasis	5.43e-05	0.000455	CcSEcCtD
Metformin—Decreased appetite—Betamethasone—psoriasis	5.42e-05	0.000454	CcSEcCtD
Metformin—Decreased appetite—Dexamethasone—psoriasis	5.42e-05	0.000454	CcSEcCtD
Metformin—NDUFS2—Metabolism—NDUFA5—psoriasis	5.41e-05	0.000332	CbGpPWpGaD
Metformin—Infection—Prednisone—psoriasis	5.4e-05	0.000452	CcSEcCtD
Metformin—Gastrointestinal disorder—Dexamethasone—psoriasis	5.38e-05	0.000451	CcSEcCtD
Metformin—Gastrointestinal disorder—Betamethasone—psoriasis	5.38e-05	0.000451	CcSEcCtD
Metformin—Fatigue—Betamethasone—psoriasis	5.38e-05	0.00045	CcSEcCtD
Metformin—Fatigue—Dexamethasone—psoriasis	5.38e-05	0.00045	CcSEcCtD
Metformin—Shock—Prednisone—psoriasis	5.34e-05	0.000448	CcSEcCtD
Metformin—Nervous system disorder—Prednisone—psoriasis	5.33e-05	0.000446	CcSEcCtD
Metformin—PRKAB1—IRS-mediated signalling—TYK2—psoriasis	5.32e-05	0.000327	CbGpPWpGaD
Metformin—Dizziness—Mycophenolate mofetil—psoriasis	5.3e-05	0.000444	CcSEcCtD
Metformin—Skin disorder—Prednisone—psoriasis	5.28e-05	0.000442	CcSEcCtD
Metformin—Hyperhidrosis—Prednisone—psoriasis	5.25e-05	0.00044	CcSEcCtD
Metformin—Vision blurred—Methotrexate—psoriasis	5.24e-05	0.000439	CcSEcCtD
Metformin—Asthenia—Hydrocortisone—psoriasis	5.24e-05	0.000439	CcSEcCtD
Metformin—Vomiting—Cyclosporine—psoriasis	5.22e-05	0.000437	CcSEcCtD
Metformin—PRKAB1—Direct p53 effectors—PCNA—psoriasis	5.19e-05	0.000318	CbGpPWpGaD
Metformin—Rash—Cyclosporine—psoriasis	5.18e-05	0.000434	CcSEcCtD
Metformin—Anorexia—Prednisone—psoriasis	5.18e-05	0.000434	CcSEcCtD
Metformin—PRKAB1—IRS-related events—TYK2—psoriasis	5.18e-05	0.000318	CbGpPWpGaD
Metformin—Dermatitis—Cyclosporine—psoriasis	5.17e-05	0.000433	CcSEcCtD
Metformin—Pruritus—Hydrocortisone—psoriasis	5.16e-05	0.000433	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—psoriasis	5.16e-05	0.000432	CcSEcCtD
Metformin—Headache—Cyclosporine—psoriasis	5.15e-05	0.000431	CcSEcCtD
Metformin—Feeling abnormal—Betamethasone—psoriasis	5.14e-05	0.00043	CcSEcCtD
Metformin—Feeling abnormal—Dexamethasone—psoriasis	5.14e-05	0.00043	CcSEcCtD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—TYK2—psoriasis	5.13e-05	0.000315	CbGpPWpGaD
Metformin—Gastrointestinal pain—Betamethasone—psoriasis	5.1e-05	0.000427	CcSEcCtD
Metformin—Gastrointestinal pain—Dexamethasone—psoriasis	5.1e-05	0.000427	CcSEcCtD
Metformin—Vomiting—Mycophenolate mofetil—psoriasis	5.09e-05	0.000427	CcSEcCtD
Metformin—Rash—Mycophenolate mofetil—psoriasis	5.05e-05	0.000423	CcSEcCtD
Metformin—Dermatitis—Mycophenolate mofetil—psoriasis	5.05e-05	0.000423	CcSEcCtD
Metformin—Headache—Mycophenolate mofetil—psoriasis	5.02e-05	0.00042	CcSEcCtD
Metformin—Malaise—Methotrexate—psoriasis	5.02e-05	0.00042	CcSEcCtD
Metformin—PRKAB1—IGF1R signaling cascade—TYK2—psoriasis	5e-05	0.000307	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—TYK2—psoriasis	5e-05	0.000307	CbGpPWpGaD
Metformin—Diarrhoea—Hydrocortisone—psoriasis	4.99e-05	0.000418	CcSEcCtD
Metformin—Urticaria—Betamethasone—psoriasis	4.95e-05	0.000415	CcSEcCtD
Metformin—Urticaria—Dexamethasone—psoriasis	4.95e-05	0.000415	CcSEcCtD
Metformin—Musculoskeletal discomfort—Prednisone—psoriasis	4.95e-05	0.000414	CcSEcCtD
Metformin—Dizziness—Prednisolone—psoriasis	4.94e-05	0.000414	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—STAT3—psoriasis	4.94e-05	0.000303	CbGpPWpGaD
Metformin—Asthenia—Triamcinolone—psoriasis	4.93e-05	0.000413	CcSEcCtD
Metformin—Abdominal pain—Betamethasone—psoriasis	4.93e-05	0.000413	CcSEcCtD
Metformin—Abdominal pain—Dexamethasone—psoriasis	4.93e-05	0.000413	CcSEcCtD
Metformin—NDUFS3—Metabolism—CYP2S1—psoriasis	4.89e-05	0.0003	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CYP2S1—psoriasis	4.89e-05	0.0003	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CYP2S1—psoriasis	4.89e-05	0.0003	CbGpPWpGaD
Metformin—Nausea—Cyclosporine—psoriasis	4.88e-05	0.000409	CcSEcCtD
Metformin—Paraesthesia—Prednisone—psoriasis	4.88e-05	0.000408	CcSEcCtD
Metformin—Pruritus—Triamcinolone—psoriasis	4.86e-05	0.000407	CcSEcCtD
Metformin—Dizziness—Hydrocortisone—psoriasis	4.83e-05	0.000404	CcSEcCtD
Metformin—Dyspepsia—Prednisone—psoriasis	4.78e-05	0.0004	CcSEcCtD
Metformin—Nausea—Mycophenolate mofetil—psoriasis	4.76e-05	0.000399	CcSEcCtD
Metformin—Myalgia—Methotrexate—psoriasis	4.74e-05	0.000397	CcSEcCtD
Metformin—Chest pain—Methotrexate—psoriasis	4.74e-05	0.000397	CcSEcCtD
Metformin—Decreased appetite—Prednisone—psoriasis	4.72e-05	0.000395	CcSEcCtD
Metformin—Rash—Prednisolone—psoriasis	4.71e-05	0.000395	CcSEcCtD
Metformin—Dermatitis—Prednisolone—psoriasis	4.71e-05	0.000394	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.7e-05	0.000394	CcSEcCtD
Metformin—Fatigue—Prednisone—psoriasis	4.68e-05	0.000392	CcSEcCtD
Metformin—Headache—Prednisolone—psoriasis	4.68e-05	0.000392	CcSEcCtD
Metformin—Discomfort—Methotrexate—psoriasis	4.68e-05	0.000392	CcSEcCtD
Metformin—Constipation—Prednisone—psoriasis	4.64e-05	0.000389	CcSEcCtD
Metformin—Vomiting—Hydrocortisone—psoriasis	4.64e-05	0.000389	CcSEcCtD
Metformin—Rash—Hydrocortisone—psoriasis	4.6e-05	0.000385	CcSEcCtD
Metformin—Dermatitis—Hydrocortisone—psoriasis	4.6e-05	0.000385	CcSEcCtD
Metformin—NDUFS2—Metabolism—CYP2S1—psoriasis	4.6e-05	0.000282	CbGpPWpGaD
Metformin—Headache—Hydrocortisone—psoriasis	4.57e-05	0.000383	CcSEcCtD
Metformin—Dizziness—Triamcinolone—psoriasis	4.55e-05	0.000381	CcSEcCtD
Metformin—Infection—Methotrexate—psoriasis	4.51e-05	0.000378	CcSEcCtD
Metformin—Feeling abnormal—Prednisone—psoriasis	4.48e-05	0.000375	CcSEcCtD
Metformin—Asthenia—Betamethasone—psoriasis	4.47e-05	0.000375	CcSEcCtD
Metformin—Asthenia—Dexamethasone—psoriasis	4.47e-05	0.000375	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—psoriasis	4.45e-05	0.000373	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—psoriasis	4.44e-05	0.000372	CcSEcCtD
Metformin—Gastrointestinal pain—Prednisone—psoriasis	4.44e-05	0.000372	CcSEcCtD
Metformin—Nausea—Prednisolone—psoriasis	4.44e-05	0.000372	CcSEcCtD
Metformin—Pruritus—Dexamethasone—psoriasis	4.41e-05	0.00037	CcSEcCtD
Metformin—Pruritus—Betamethasone—psoriasis	4.41e-05	0.00037	CcSEcCtD
Metformin—Skin disorder—Methotrexate—psoriasis	4.41e-05	0.000369	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—psoriasis	4.39e-05	0.000368	CcSEcCtD
Metformin—Vomiting—Triamcinolone—psoriasis	4.37e-05	0.000366	CcSEcCtD
Metformin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	4.36e-05	0.000267	CbGpPWpGaD
Metformin—Nausea—Hydrocortisone—psoriasis	4.34e-05	0.000363	CcSEcCtD
Metformin—Rash—Triamcinolone—psoriasis	4.33e-05	0.000363	CcSEcCtD
Metformin—Dermatitis—Triamcinolone—psoriasis	4.33e-05	0.000363	CcSEcCtD
Metformin—Anorexia—Methotrexate—psoriasis	4.33e-05	0.000362	CcSEcCtD
Metformin—Urticaria—Prednisone—psoriasis	4.31e-05	0.000361	CcSEcCtD
Metformin—Headache—Triamcinolone—psoriasis	4.31e-05	0.000361	CcSEcCtD
Metformin—Abdominal pain—Prednisone—psoriasis	4.29e-05	0.00036	CcSEcCtD
Metformin—Diarrhoea—Betamethasone—psoriasis	4.27e-05	0.000357	CcSEcCtD
Metformin—Diarrhoea—Dexamethasone—psoriasis	4.27e-05	0.000357	CcSEcCtD
Metformin—Hypotension—Methotrexate—psoriasis	4.24e-05	0.000355	CcSEcCtD
Metformin—PRKAB1—Signaling by Insulin receptor—TYK2—psoriasis	4.15e-05	0.000255	CbGpPWpGaD
Metformin—Musculoskeletal discomfort—Methotrexate—psoriasis	4.14e-05	0.000346	CcSEcCtD
Metformin—Dizziness—Dexamethasone—psoriasis	4.12e-05	0.000345	CcSEcCtD
Metformin—Dizziness—Betamethasone—psoriasis	4.12e-05	0.000345	CcSEcCtD
Metformin—Nausea—Triamcinolone—psoriasis	4.08e-05	0.000342	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—psoriasis	4.08e-05	0.000341	CcSEcCtD
Metformin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	4.06e-05	0.000249	CbGpPWpGaD
Metformin—Dyspnoea—Methotrexate—psoriasis	4.05e-05	0.000339	CcSEcCtD
Metformin—Somnolence—Methotrexate—psoriasis	4.04e-05	0.000338	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—psoriasis	4e-05	0.000335	CcSEcCtD
Metformin—Vomiting—Dexamethasone—psoriasis	3.97e-05	0.000332	CcSEcCtD
Metformin—Vomiting—Betamethasone—psoriasis	3.97e-05	0.000332	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—psoriasis	3.95e-05	0.00033	CcSEcCtD
Metformin—Rash—Dexamethasone—psoriasis	3.93e-05	0.000329	CcSEcCtD
Metformin—Rash—Betamethasone—psoriasis	3.93e-05	0.000329	CcSEcCtD
Metformin—Dermatitis—Betamethasone—psoriasis	3.93e-05	0.000329	CcSEcCtD
Metformin—Dermatitis—Dexamethasone—psoriasis	3.93e-05	0.000329	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—psoriasis	3.92e-05	0.000328	CcSEcCtD
Metformin—Fatigue—Methotrexate—psoriasis	3.91e-05	0.000328	CcSEcCtD
Metformin—Headache—Betamethasone—psoriasis	3.91e-05	0.000327	CcSEcCtD
Metformin—Headache—Dexamethasone—psoriasis	3.91e-05	0.000327	CcSEcCtD
Metformin—Asthenia—Prednisone—psoriasis	3.9e-05	0.000326	CcSEcCtD
Metformin—Pruritus—Prednisone—psoriasis	3.84e-05	0.000322	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—psoriasis	3.74e-05	0.000313	CcSEcCtD
Metformin—Diarrhoea—Prednisone—psoriasis	3.72e-05	0.000311	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—psoriasis	3.71e-05	0.000311	CcSEcCtD
Metformin—NDUFB11—Metabolism—CARM1—psoriasis	3.71e-05	0.000227	CbGpPWpGaD
Metformin—ND1—Metabolism—NDUFA5—psoriasis	3.71e-05	0.000227	CbGpPWpGaD
Metformin—Nausea—Dexamethasone—psoriasis	3.7e-05	0.00031	CcSEcCtD
Metformin—Nausea—Betamethasone—psoriasis	3.7e-05	0.00031	CcSEcCtD
Metformin—Urticaria—Methotrexate—psoriasis	3.61e-05	0.000302	CcSEcCtD
Metformin—Dizziness—Prednisone—psoriasis	3.59e-05	0.000301	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—psoriasis	3.59e-05	0.000301	CcSEcCtD
Metformin—Vomiting—Prednisone—psoriasis	3.45e-05	0.000289	CcSEcCtD
Metformin—Rash—Prednisone—psoriasis	3.42e-05	0.000287	CcSEcCtD
Metformin—Dermatitis—Prednisone—psoriasis	3.42e-05	0.000287	CcSEcCtD
Metformin—Headache—Prednisone—psoriasis	3.4e-05	0.000285	CcSEcCtD
Metformin—NDUFB3—Metabolism—CARM1—psoriasis	3.39e-05	0.000208	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—CARM1—psoriasis	3.39e-05	0.000208	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—CARM1—psoriasis	3.39e-05	0.000208	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—CARM1—psoriasis	3.39e-05	0.000208	CbGpPWpGaD
Metformin—PRKAB1—AMPK Signaling—TP53—psoriasis	3.36e-05	0.000206	CbGpPWpGaD
Metformin—Asthenia—Methotrexate—psoriasis	3.26e-05	0.000273	CcSEcCtD
Metformin—Nausea—Prednisone—psoriasis	3.23e-05	0.00027	CcSEcCtD
Metformin—Pruritus—Methotrexate—psoriasis	3.21e-05	0.000269	CcSEcCtD
Metformin—SLC22A3—SLC-mediated transmembrane transport—CP—psoriasis	3.16e-05	0.000194	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND4L—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND6—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND2—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND5—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND4—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND3—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—ND1—Metabolism—CYP2S1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—CARM1—psoriasis	3.15e-05	0.000193	CbGpPWpGaD
Metformin—Diarrhoea—Methotrexate—psoriasis	3.11e-05	0.00026	CcSEcCtD
Metformin—SLC47A1—Transmembrane transport of small molecules—CP—psoriasis	3.07e-05	0.000188	CbGpPWpGaD
Metformin—Dizziness—Methotrexate—psoriasis	3e-05	0.000251	CcSEcCtD
Metformin—SLC47A1—Transmembrane transport of small molecules—CARM1—psoriasis	2.93e-05	0.00018	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—JUN—psoriasis	2.89e-05	0.000177	CbGpPWpGaD
Metformin—Vomiting—Methotrexate—psoriasis	2.89e-05	0.000242	CcSEcCtD
Metformin—Rash—Methotrexate—psoriasis	2.86e-05	0.00024	CcSEcCtD
Metformin—Dermatitis—Methotrexate—psoriasis	2.86e-05	0.000239	CcSEcCtD
Metformin—Headache—Methotrexate—psoriasis	2.84e-05	0.000238	CcSEcCtD
Metformin—NDUFV3—Metabolism—CARM1—psoriasis	2.81e-05	0.000172	CbGpPWpGaD
Metformin—Nausea—Methotrexate—psoriasis	2.7e-05	0.000226	CcSEcCtD
Metformin—PRKAB1—Signaling Pathways—HCAR2—psoriasis	2.69e-05	0.000165	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—IL6—psoriasis	2.6e-05	0.00016	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—IL6—psoriasis	2.53e-05	0.000155	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—IL6—psoriasis	2.51e-05	0.000154	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—IL6—psoriasis	2.44e-05	0.00015	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—IL6—psoriasis	2.44e-05	0.00015	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CARM1—psoriasis	2.39e-05	0.000147	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CARM1—psoriasis	2.39e-05	0.000147	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CARM1—psoriasis	2.39e-05	0.000147	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TAGAP—psoriasis	2.33e-05	0.000143	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—CAT—psoriasis	2.28e-05	0.00014	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CARM1—psoriasis	2.24e-05	0.000138	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—CAT—psoriasis	2.08e-05	0.000128	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—CAT—psoriasis	2.08e-05	0.000128	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—CAT—psoriasis	2.08e-05	0.000128	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—CAT—psoriasis	2.08e-05	0.000128	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—IL6—psoriasis	2.03e-05	0.000125	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	1.98e-05	0.000122	CbGpPWpGaD
Metformin—ND4L—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—ND5—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—ND3—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—ND2—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—ND4—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—ND6—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—CAT—psoriasis	1.94e-05	0.000119	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—TP53—psoriasis	1.91e-05	0.000117	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	1.85e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—APOE—psoriasis	1.77e-05	0.000109	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—CAT—psoriasis	1.73e-05	0.000106	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NDUFA5—psoriasis	1.73e-05	0.000106	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—APOE—psoriasis	1.62e-05	9.94e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—APOE—psoriasis	1.62e-05	9.94e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—APOE—psoriasis	1.62e-05	9.94e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—APOE—psoriasis	1.62e-05	9.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—CP—psoriasis	1.6e-05	9.85e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PPARG—psoriasis	1.54e-05	9.47e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CARM1—psoriasis	1.54e-05	9.44e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—CARM1—psoriasis	1.53e-05	9.39e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—APOE—psoriasis	1.51e-05	9.24e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CAT—psoriasis	1.47e-05	9.01e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CAT—psoriasis	1.47e-05	9.01e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CAT—psoriasis	1.47e-05	9.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2S1—psoriasis	1.47e-05	9.01e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PPARG—psoriasis	1.41e-05	8.66e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PPARG—psoriasis	1.41e-05	8.66e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PPARG—psoriasis	1.41e-05	8.66e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PPARG—psoriasis	1.41e-05	8.66e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL20—psoriasis	1.4e-05	8.57e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CAT—psoriasis	1.38e-05	8.47e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—APOE—psoriasis	1.34e-05	8.24e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PPARG—psoriasis	1.31e-05	8.05e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PPARG—psoriasis	1.17e-05	7.17e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—APOE—psoriasis	1.14e-05	7e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—APOE—psoriasis	1.14e-05	7e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—APOE—psoriasis	1.14e-05	7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NDUFA5—psoriasis	1.08e-05	6.65e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—APOE—psoriasis	1.07e-05	6.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NDUFA5—psoriasis	1.01e-05	6.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	1.01e-05	6.18e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PPARG—psoriasis	9.94e-06	6.1e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PPARG—psoriasis	9.94e-06	6.1e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PPARG—psoriasis	9.94e-06	6.1e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	9.6e-06	5.89e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CAT—psoriasis	9.46e-06	5.81e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	9.38e-06	5.76e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PPARG—psoriasis	9.34e-06	5.74e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2S1—psoriasis	9.21e-06	5.65e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	8.95e-06	5.49e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2S1—psoriasis	8.58e-06	5.27e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SOCS1—psoriasis	7.69e-06	4.72e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—APOE—psoriasis	7.35e-06	4.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CARM1—psoriasis	7.17e-06	4.4e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—psoriasis	6.4e-06	3.93e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOE—psoriasis	5.67e-06	3.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—LEP—psoriasis	5.67e-06	3.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKBIA—psoriasis	5.29e-06	3.25e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CARM1—psoriasis	4.5e-06	2.76e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAT—psoriasis	4.41e-06	2.71e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TYK2—psoriasis	4.33e-06	2.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CARM1—psoriasis	4.19e-06	2.57e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—psoriasis	3.77e-06	2.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—psoriasis	3.51e-06	2.15e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOE—psoriasis	3.43e-06	2.1e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKB1—psoriasis	3.37e-06	2.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—psoriasis	3.06e-06	1.88e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—psoriasis	3.03e-06	1.86e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—psoriasis	2.98e-06	1.83e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAT—psoriasis	2.77e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAT—psoriasis	2.58e-06	1.58e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—psoriasis	2.31e-06	1.42e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOE—psoriasis	2.15e-06	1.32e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—psoriasis	2.12e-06	1.3e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOE—psoriasis	2e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—psoriasis	1.87e-06	1.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—psoriasis	1.74e-06	1.07e-05	CbGpPWpGaD
